Abstract
Tacca leontopetaloides (T. leontopetaloides) contain a number of active compounds such as flavonoids, tannins, phenolics, steroids, and alkaloids. The active compounds from plants have been shown to reduce the risk of cardiovascular disease by lowering cholesterol levels by inhibiting the enzyme 3-hydroxy-3-methylglutaryl-coenzym A (HMG-CoA) reductase activity. This study aims to investigate the potential active compounds in the ethanolic extract of Tacca tubers (T. leontopetaloides) from the Banyak Islands, Aceh Singkil Regency, Aceh Province both in vitro and in silico. Tacca tubers contain secondary metabolites including flavonoids, phenolics, tannins, steroids and saponins, according to phytochemical screening. In vitro investigation of ethanolic extract of Tacca tuber revealed inhibitory activity of HMG Co-A reductase with an IC50 value of 4.92 ppm. Based on the in silico study, active compound from the extract, namely Stigmasterol with the highest binding affinities with HMG Co-A reductase (−7.2 kcal/mol). As a comparison, the inhibition of HMG Co-A reductase activity by simvastatin with an IC50 4.62 ppm and binding affinity −8.0 Kcal/mol. Our findings suggest that the ethanolic extract of Tacca tuber (T. leontopetaloides) from Banyak Islands, Aceh Province has the potential to inhibit the activity of HMG Co-A reductase.
Funder
Direktorat Riset, Teknologi, dan Pengabdian kepada Masyarakat—Direktorat Jenderal Pendidikan Tinggi, Riset, dan Teknologi—Kementerian Pendidikan, Kebudayaan, Riset, dan Teknologi
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference59 articles.
1. World Health Organization (WHO) (2022). Cardiovascular Disease (CVDs).
2. Preventing Cardiovascular Heart Disease: Promising Nutraceutical and Non-Nutraceutical Treatments for Cholesterol Management;Johnston;Pharmacol. Res.,2017
3. Homozygous Familial Hypercholesterolaemia: New Insights and Guidance for Clinicians to Improve Detection and Clinical Management. A Position Paper Fromthe Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur. Heart J.,2014
4. Gesto, D.S., Pereira, C.M.S., Cerqueira, N.M.F.S., and Sousa, S.F. (2020). An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia. Molecules, 25.
5. HMG-CoA Reductase Inhibitory Activity and Phytocomponent Investigation of Basella Alba Leaf Extract as a Treatment for Hypercholesterolemia;Baskaran;Drug Des. Devel. Ther.,2015
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献